We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
1001
Sterling Investment Management
Arizona
$2.75M -$249K -7,913 -8%
WFI
1002
West Family Investments
California
$2.72M
HCMNY
1003
Howard Capital Management (New York)
New York
$2.71M
PWW
1004
Pettyjohn Wood & White
Virginia
$2.71M +$73K +2,319 +3%
WIS
1005
Wright Investors Service
Connecticut
$2.71M +$987K +31,383 +55%
BE
1006
Bonness Enterprises
District of Columbia
$2.7M
OCM
1007
One Capital Management
California
$2.7M -$29.7K -944 -1%
AOWM
1008
Alpha Omega Wealth Management
Virginia
$2.69M +$2.76M +87,803 New
BCMO
1009
Buckingham Capital Management (Ohio)
Ohio
$2.69M +$147K +4,687 +6%
FMW
1010
Farr Miller & Washington
District of Columbia
$2.67M +$334K +10,618 +14%
HCM
1011
Howland Capital Management
Massachusetts
$2.65M +$251K +7,964 +10%
SLG
1012
Stanley-Laman Group
Pennsylvania
$2.64M -$139K -4,404 -5%
GD
1013
Grandfield & Dodd
New York
$2.64M
SCA
1014
Salient Capital Advisors
Texas
$2.63M +$228K +7,236 +9%
HKIM
1015
Hayek Kallen Investment Management
Alabama
$2.63M -$12.2K -387 -0.4%
MLIC
1016
Mandatum Life Insurance Company
Finland
$2.62M +$2.69M +85,518 New
BHC
1017
Bowen Hanes & Co
Florida
$2.62M -$12.4K -395 -0.5%
LWCFA
1018
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2.61M -$58.4K -1,857 -2%
MCM
1019
Maryland Capital Management
Maryland
$2.61M +$114K +3,614 +4%
FM
1020
Forward Management
California
$2.6M -$163K -5,167 -6%
SPC
1021
Sigma Planning Corp
Michigan
$2.6M +$76.9K +2,446 +3%
HB
1022
Homrich & Berg
Georgia
$2.59M -$89K -2,830 -3%
MSU
1023
Mizuho Securities USA
New York
$2.58M +$2.65M +84,320 New
EHC
1024
Everett Harris & Co
California
$2.57M -$29.8K -946 -1%
KFA
1025
Kelleher Financial Advisors
New York
$2.56M

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.